19 min listen
Biomarkers - miracle or marketing?
FromThe BMJ Podcast
ratings:
Length:
18 minutes
Released:
Jul 18, 2017
Format:
Podcast episode
Description
The BMJ has been campaigning for an end to “too much medicine” - the pernicious effect of marketing on the range of tests and treatments that doctors offer patients - tests and treatments which are motivated by the financial reward to the system, than the health of the individual.
A new analysis on BMJ.com takes a look at what’s happening in the the first part of that - testing. New biomarkers for disease, and new ways of monitoring, have the potential to diagnose disease more quickly, but is the hype backed by science?
Bjorn Hoffman professor of medical ethics at Norwegian University of Science and Technology and one of the authors of that article doesn’t think so - and joins us on the podcast to discuss.
Read the full analysis:
http://www.bmj.com/content/358/bmj.j3314
A new analysis on BMJ.com takes a look at what’s happening in the the first part of that - testing. New biomarkers for disease, and new ways of monitoring, have the potential to diagnose disease more quickly, but is the hype backed by science?
Bjorn Hoffman professor of medical ethics at Norwegian University of Science and Technology and one of the authors of that article doesn’t think so - and joins us on the podcast to discuss.
Read the full analysis:
http://www.bmj.com/content/358/bmj.j3314
Released:
Jul 18, 2017
Format:
Podcast episode
Titles in the series (100)
Bias in clinical guidelines, and giving birth at home: Despite repeated calls to prohibit or limit conflicts of interests among authors and sponsors of clinical guidelines, the problem persists. Jeanne Lenzer explains what's going wrong.And is giving birth at home as safe for the mother as giving birth i... by The BMJ Podcast